Duquesne Family Office »

Bicycle Therapeutics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.7M 190k 24.90

More positions owned by Duquesne Family Office

Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation (MSFT)
Coupang Cl A (CPNG)
Teck Resources CL B (TECK)
Vistra Energy (VST)
Natera (NTRA)
NVIDIA Corporation (NVDA)
Coherent Corp (COHR)
General Electric Com New (GE)
Woodward Governor Company (WWD)
Seagate Technology Hldngs Pl Ord Shs (STX)
Arista Networks (ANET)
Flex Ord (FLEX)
Zoominfo Technologies Common Stock (ZI)
News Corp Cl A (NWSA)

View all positions for Duquesne Family Office

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Paradigm Biocapital Advisors
Armistice Capital
Morgan Stanley
First Light Asset Management
Westfield Capital Management Company
Suvretta Capital Management
Candriam Luxembourg S.C.A.
Bnp Paribas Investment Partners
RA Capital Management
BlackRock
Axa
Parkman Healthcare Partners
Schonfeld Strategic Advisors
T. Rowe Price Associates

View all funds holding Bicycle Therapeutics